Arun Sanyal
Corporate Officer/Principal en Medical College of Virginia .
Cargos activos de Arun Sanyal
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Medical College of Virginia | Corporate Officer/Principal | - | - |
| National Institute of Diabetes & Digestive & Kidney Diseases | Corporate Officer/Principal | - | - |
IFM Therapeutics LLC
 IFM Therapeutics LLC Pharmaceuticals: MajorHealth Technology IFM Therapeutics LLC engages in the development and transformation of immunotherapy for patients with serious diseases. It focuses on developing small molecule drugs that target the innate immune system. The company was founded by Gary D. Glick, Luigi Franchi, Matthias Geyer, Eicke Latz, and Anthony W. Opipari, Jr. in 2015 and is headquartered in Boston, MA. | Corporate Officer/Principal | - | - |
One Way Liver SL
 One Way Liver SL Miscellaneous Commercial ServicesCommercial Services One Way Liver SL designs and develops diagnostic solutions for liver conditions. It designs and develops of non-invasive diagnostic solutions for hepatic conditions, such as fatty liver disease and non-alcoholic steatohepatitis. The firm also provides research and clinical testing services to clients in the pharmaceutical and biomedical product industries. The company was founded by José Maria Mato de la Paz in 2002 and is headquartered in Derio, Spain. | Corporate Officer/Principal | - | - |
Historial de carrera de Arun Sanyal
Estadísticas
Internacional
| Estados Unidos | 4 |
| España | 2 |
Operativa
| Corporate Officer/Principal | 4 |
Sectorial
| Consumer Services | 2 |
| Government | 2 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
| National Institute of Diabetes & Digestive & Kidney Diseases | Government |
IFM Therapeutics LLC
IFM Therapeutics LLC Pharmaceuticals: MajorHealth Technology IFM Therapeutics LLC engages in the development and transformation of immunotherapy for patients with serious diseases. It focuses on developing small molecule drugs that target the innate immune system. The company was founded by Gary D. Glick, Luigi Franchi, Matthias Geyer, Eicke Latz, and Anthony W. Opipari, Jr. in 2015 and is headquartered in Boston, MA. | Health Technology |
One Way Liver SL
One Way Liver SL Miscellaneous Commercial ServicesCommercial Services One Way Liver SL designs and develops diagnostic solutions for liver conditions. It designs and develops of non-invasive diagnostic solutions for hepatic conditions, such as fatty liver disease and non-alcoholic steatohepatitis. The firm also provides research and clinical testing services to clients in the pharmaceutical and biomedical product industries. The company was founded by José Maria Mato de la Paz in 2002 and is headquartered in Derio, Spain. | Commercial Services |
- Bolsa de valores
- Insiders
- Arun Sanyal
- Experiencia
